Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Oasis Management Co Ltd. Trims Position in Carmike Cinemas Inc (CKEC)

In a recent 13D filing, Oasis Management reported its stake in Carmike Cinemas, Inc. (NASDAQ:CKEC). The filing with the US Securities and Exchange Commission showed that Oasis owns some 959,800 shares of Carmike Cinemas, down from 1.24 million shares it disclosed in its last 13F filing. Following the decline, Oasis holds 3.9% of Carmike Cinemas’ outstanding stock.

Among the funds followed by Insider Monkey, 22 reported long positions in Carmike Cinemas as of the end of 2015, down by 15% over the quarter.  Manatuck Hill Partners, managed by Mark Broach, holds the largest position in Carmike Cinemas, Inc. (NASDAQ:CKEC), worth $19.9 million and comprising 6.7% of its 13F portfolio. The second most bullish fund manager is Israel Englander’s Millennium Management, which holds a $16.1 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other members of the smart money that hold long positions contain Brett Hendrickson’s Nokomis Capital, Ken Griffin’s Citadel Investment Group and Julian Allen’s Spitfire Capital.

Moreover, there was a specific group of hedgies who were dropping their positions entirely heading into Q4. At the top of the heap, Ken Grossman and Glen Schneider’s SG Capital Management cut the biggest position of all the hedgies watched by Insider Monkey, valued at about $12.6 million in stock, and Zac Hirzel’s Hirzel Capital Management was right behind this move, as the fund sold off about $4.3 million worth of shares.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Oasis Management Company Ltd 0 959,842 0 959,842 959,842 3.9%
Oasis Investments II Master Fund Ltd 0 959,842 0 959,842 959,842 3.9%
Seth Fischer 0 959,842 0 959,842 959,842 3.9%

Page 1 of 8 SEC Filing

Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Carmike Cinemas,

(Name of Issuer)

Common stock,
$0.03 par value

(Title of Class of Securities)


(CUSIP Number)

Oasis Management
Company Ltd.

c/o Oasis Management (Hong Kong) LLC

21/F Man Yee Building

68 Des Voeux Road, Central

Hong Kong

Attention: Phillip Meyer

(852) 2847-7708

with a copy to:

Schulte Roth & Zabel LLP

919 Third Avenue

New York, NY 10022

Attention: Eleazer N. Klein, Esq.

(212) 756-2000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

March 16,

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 7 Pages)

Follow Carmike Cinemas Inc (NASDAQ:CKEC)
Trade (NASDAQ:CKEC) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.